Datatrak International, Inc. SC 13D
|
|
|
|
OMB APPROVAL |
|
|
OMB Number: 3235-0145 |
|
|
Expires: February 28, 2006
|
|
|
Estimated average burden hours per response...15 |
|
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. )*
DATATRAK
INTERNATIONAL, INC.
(Name of Issuer)
(Title of Class of Securities)
(CUSIP Number)
Arthur
C. Hall III
Calfee, Halter & Griswold LLP
800 Superior Avenue, Suite 1400
Cleveland, OH 44114-2688
216-622-8667
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
(Date of Event Which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
|
|
|
|
|
|
|
|
|
|
CUSIP No. |
|
238134 10 0 |
|
Page |
|
2 |
|
of |
|
5 |
|
|
|
|
|
|
1 |
|
NAMES OF REPORTING PERSONS:
Jim Bob Ward |
| |
|
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY): |
|
|
|
|
|
|
2 |
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS):
|
|
(a) o |
|
(b) o |
|
|
|
3 |
|
SEC USE ONLY: |
|
|
|
|
|
|
|
4 |
|
SOURCE OF FUNDS (SEE INSTRUCTIONS): |
|
|
|
N/A |
|
|
|
5 |
|
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e): |
|
|
|
o |
|
|
|
6 |
|
CITIZENSHIP OR PLACE OF ORGANIZATION: |
|
|
|
United States
|
|
|
|
|
|
7 |
|
SOLE VOTING POWER: |
|
|
|
NUMBER OF |
|
673,908 |
|
|
|
|
SHARES |
8 |
|
SHARED VOTING POWER: |
BENEFICIALLY |
|
|
OWNED BY |
|
0 |
|
|
|
|
EACH |
9 |
|
SOLE DISPOSITIVE POWER: |
REPORTING |
|
|
PERSON |
|
673,908 |
|
|
|
|
WITH |
10 |
|
SHARED DISPOSITIVE POWER: |
|
|
|
|
|
0 |
|
|
|
11 |
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: |
|
|
|
673,908 |
|
|
|
12 |
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS): |
|
|
|
o
|
|
|
|
13 |
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): |
|
|
|
5.9% |
|
|
|
14 |
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS): |
|
|
|
IN |
TABLE OF CONTENTS
|
|
|
|
|
CUSIP No. 238134 10 0
|
|
13D
|
|
Page 3 of 5 Pages |
Item 1.
Security and Issuer.
This Statement on Schedule 13D (Schedule 13D) relates to the common shares, without par
value, of DATATRAK International, Inc. (DATATRAK or the Company). The principal executive
offices of DATATRAK are located at 6150 Parkland Boulevard, Suite 100, Mayfield Heights, Ohio
44124.
Item 2. Identity and Background.
This Schedule 13D is being filed by Jim Bob Ward, a United States citizen and Vice President
of eClinical Development of DATATRAK. His principal business address is 6150 Parkland Boulevard,
Suite 100, Mayfield Heights, Ohio 44124.
During the past five years, Mr. Ward has not been convicted in a criminal proceeding of any
crime or misdemeanor (excluding traffic violations or similar misdemeanors). During the past five
years, Mr. Ward has not been a party to a civil proceeding in any judicial or administrative body
which resulted in being, either now or in the past, subject to any judgment, decree or final order
enjoining future violations of, or prohibiting or mandating activities subject to, federal or state
securities laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration.
No funds or other consideration were involved in the acquisition of beneficial ownership by
Mr. Ward of the 673,908 common shares of DATATRAK.
Item 4. Purpose of Transaction.
Pursuant to the merger agreement by and among DATATRAK, ClickFind, Inc. (ClickFind), CF
Merger Sub, Inc., a wholly-owned subsidiary of DATATRAK, the shareholders of ClickFind and Jim Bob
Ward as shareholder representative, dated February 13, 2006, certain shareholders received a
combination of cash, promissory notes and DATATRAK common stock for each share of ClickFind common
stock. The exact composition of consideration received was determined by a formula contained in
the merger agreement. Pursuant to the merger consideration formula, the 685,850 common shares of
DATATRAK that Mr. Ward was initially entitled to receive was reduced by 11,942 shares of DATATRAK
in satisfaction of prior obligations owed to ClickFind related to the repayment of a promissory
note in favor of ClickFind in connection with the exercise of stock options, as well as withholding
taxes associated with equity compensation awards made by ClickFind. The shares listed in Item 3
above represent the stock portion of the merger consideration received by Mr. Ward in exchange for
his shares of ClickFind, after the 11,942 shares were deducted.
Mr. Ward
acquired the shares for investment purposes and does not presently have any plan or proposal which relates to or would result in any
of the following: the acquisition or disposition by any person of additional securities of
DATATRAK; an extraordinary corporate transaction involving DATATRAK or its subsidiaries; a sale or
transfer of a material amount of DATATRAKs or any of its subsidiaries assets; any change in the
present board of directors or management of DATATRAK; any material change in the present
capitalization or dividend policy of DATATRAK; any other material change in DATATRAKs corporate
structure; any changes to DATATRAKs charter, bylaws or instruments corresponding thereto or any
|
|
|
|
|
CUSIP No. 238134 10 0
|
|
13D
|
|
Page 4 of 5 Pages |
other action which may impede the acquisition of control by any person; causing a class of
securities of DATATRAK to be delisted from a national securities exchange or to cease to be
authorized to be quoted in an inter-dealer quotation system of a registered national securities
association; a class of equity securities of DATATRAK becoming eligible for termination of
registration pursuant to section 12(g)(4) of the Securities Exchange Act of 1934; or any action
similar to any of those described in this paragraph.
Item 5. Interest in Securities of the Issuer.
Mr. Ward beneficially owns 673,908 common shares of DATATRAK, or 5.9% of the common shares of
DATATRAK, based upon 11,346,745 common shares outstanding as of February 20, 2006. The information
contained on the cover page to this Schedule 13D is incorporated herein by reference.
Item 6. Contracts, Arrangements, Understanding or Relationships with Respect to Securities of the Issuer.
Mr. Ward
has no contracts, arrangements, understandings or relationships (legal or otherwise)
with any person with respect to any securities of DATATRAK, including but not limited to transfer
or voting of any of the securities, finders fees, joint ventures, loan or option arrangements,
puts or calls, guarantees of profits, division of profits or loss, or the giving or withholding of
proxies.
Item 7. Materials to be Filed as Exhibits.
1. |
|
Agreement and Plan of Merger dated as of February 13, 2006, among DATATRAK International,
Inc., CF Merger Sub, Inc., ClickFind, Inc., the shareholders of ClickFind, Inc. and Jim Bob
Ward as Shareholder Representative (incorporated by reference from Exhibit 10.1 of the
Issuers Current Report on Form 8-K dated February 13, 2006 and filed with the SEC on February
17, 2006). |
|
|
|
|
|
CUSIP No. 238134 10 0
|
|
13D
|
|
Page 5 of 5 Pages |
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify that the
information set forth in this statement is true, complete and correct.
|
|
|
|
|
Dated: February 23, 2006 |
Jim Bob Ward
|
|
|
By: |
/s/ Jim Bob Ward
|
|
|
|
Name: |
Jim Bob Ward, Vice President of eClinical |
|
|
|
Development |
|
|